Leif W Ellisen (Leif Ellisen)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 36

Top Venues

Nature communications

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

NPJ breast cancer

Massachusetts General Hospital Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Massachusetts General Hospital Cancer Center Jan 01 1996

United States

Professor and Program Director, Breast Oncology

Publications

Yumin Wang, Boya Gao, Luyuan Zhang, Xudong Wang, Xiaolan Zhu, Haibo Yang, Fengqi Zhang, Xueping Zhu, Badi Zhou, Sean Yao, Aiko Nagayama, Sanghoon Lee, Jian Ouyang, Siang-Boon Koh, Eric L Eisenhauer, Dominique Zarrella, Kate Lu, Bo R Rueda, Lee Zou, Xiaofeng A Su, Oladapo O Yeku, Leif W Ellisen, Xiao-Song Wang, Li Lan
Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair. Nature communications 15 (1) (2024)
Yael Bar, Jennifer C Keenan, Andrzej Niemierko, Arielle J Medford, Steven Jay Isakoff, Leif W Ellisen, Aditya Bardia, Neelima Vidula
Genomic spectrum of actionable alterations in serial cell free DNA (cfDNA) analysis of patients with metastatic breast cancer. NPJ breast cancer 10 (1) (2024)
Yumin Wang, Boya Gao, Luyuan Zhang, Xudong Wang, Xiaolan Zhu, Haibo Yang, Fengqi Zhang, Xueping Zhu, Badi Zhou, Sean Yao, Aiko Nagayama, Sanghoon Lee, Jian Ouyang, Siang-Boon Koh, Eric L Eisenhauer, Dominique Zarrella, Kate Lu, Bo R Rueda, Lee Zou, Xiaofeng A Su, Oladapo O Yeku, Leif W Ellisen, Xiao-Song Wang, Li Lan
Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair. Nature communications 15 (1) (2024)
Yumin Wang, Boya Gao, Luyuan Zhang, Xudong Wang, Xiaolan Zhu, Haibo Yang, Fengqi Zhang, Xueping Zhu, Badi Zhou, Sean Yao, Aiko Nagayama, Sanghoon Lee, Jian Ouyang, Siang-Boon Koh, Eric L Eisenhauer, Dominique Zarrella, Kate Lu, Bo R Rueda, Lee Zou, Xiaofeng A Su, Oladapo O Yeku, Leif W Ellisen, Xiao-Song Wang, Li Lan
Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair. Nature communications 15 (1) (2024)
Aditya Bardia, Sheng Sun, Nayana Thimmiah, James T T Coates, Bogang Wu, Rachel Occhiogrosso Abelman, Laura M Spring, Beverly Moy, Phoebe Ryan, Mark N Melkonyan, Ann H Partridge, Dejan Juric, Jeffrey M Peppercorn, Heather A Parsons, Seth A Wander, Victoria Attaya, Brenda Lormil, Maria Shellock, Aiko Nagayama, Veerle Bossuyt, Steven Jay Isakoff, Sara M Tolaney, Leif W Ellisen
Antibody Drug Conjugate Sacituzumab Govitecan Enables A Sequential TOP1/PARP Inhibitor Cancer Therapy Strategy in Breast Cancer Patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Arielle J Medford, Leif W Ellisen
Optimizing Access to Liquid Biopsy in the Present and Future Cancer Landscape. JCO precision oncology 8 (2024)
Yael Bar, Jennifer C Keenan, Andrzej Niemierko, Arielle J Medford, Steven Jay Isakoff, Leif W Ellisen, Aditya Bardia, Neelima Vidula
Genomic spectrum of actionable alterations in serial cell free DNA (cfDNA) analysis of patients with metastatic breast cancer. NPJ breast cancer 10 (1) (2024)
Yumin Wang, Boya Gao, Luyuan Zhang, Xudong Wang, Xiaolan Zhu, Haibo Yang, Fengqi Zhang, Xueping Zhu, Badi Zhou, Sean Yao, Aiko Nagayama, Sanghoon Lee, Jian Ouyang, Siang-Boon Koh, Eric L Eisenhauer, Dominique Zarrella, Kate Lu, Bo R Rueda, Lee Zou, Xiaofeng A Su, Oladapo O Yeku, Leif W Ellisen, Xiao-Song Wang, Li Lan
Author Correction: Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair. Nature communications 15 (1) (2024)
Yumin Wang, Boya Gao, Luyuan Zhang, Xudong Wang, Xiaolan Zhu, Haibo Yang, Fengqi Zhang, Xueping Zhu, Badi Zhou, Sean Yao, Aiko Nagayama, Sanghoon Lee, Jian Ouyang, Siang-Boon Koh, Eric L Eisenhauer, Dominique Zarrella, Kate Lu, Bo R Rueda, Lee Zou, Xiaofeng A Su, Oladapo O Yeku, Leif W Ellisen, Xiao-Song Wang, Li Lan
Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair. Nature communications 15 (1) (2024)
Yael Bar, Jennifer C Keenan, Andrzej Niemierko, Arielle J Medford, Steven Jay Isakoff, Leif W Ellisen, Aditya Bardia, Neelima Vidula
Genomic spectrum of actionable alterations in serial cell free DNA (cfDNA) analysis of patients with metastatic breast cancer. NPJ breast cancer 10 (1) (2024)
Yumin Wang, Boya Gao, Luyuan Zhang, Xudong Wang, Xiaolan Zhu, Haibo Yang, Fengqi Zhang, Xueping Zhu, Badi Zhou, Sean Yao, Aiko Nagayama, Sanghoon Lee, Jian Ouyang, Siang-Boon Koh, Eric L Eisenhauer, Dominique Zarrella, Kate Lu, Bo R Rueda, Lee Zou, Xiaofeng A Su, Oladapo O Yeku, Leif W Ellisen, Xiao-Song Wang, Li Lan
Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair. Nature communications 15 (1) (2024)
Yael Bar, Jennifer C Keenan, Andrzej Niemierko, Arielle J Medford, Steven Jay Isakoff, Leif W Ellisen, Aditya Bardia, Neelima Vidula
Genomic spectrum of actionable alterations in serial cell free DNA (cfDNA) analysis of patients with metastatic breast cancer. NPJ breast cancer 10 (1) (2024)
Aditya Bardia, Sheng Sun, Nayana Thimmiah, James T T Coates, Bogang Wu, Rachel Occhiogrosso Abelman, Laura M Spring, Beverly Moy, Phoebe Ryan, Mark N Melkonyan, Ann H Partridge, Dejan Juric, Jeffrey M Peppercorn, Heather A Parsons, Seth A Wander, Victoria Attaya, Brenda Lormil, Maria Shellock, Aiko Nagayama, Veerle Bossuyt, Steven Jay Isakoff, Sara M Tolaney, Leif W Ellisen
Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Aditya Bardia, Sheng Sun, Nayana Thimmiah, James T T Coates, Bogang Wu, Rachel Occhiogrosso Abelman, Laura M Spring, Beverly Moy, Phoebe Ryan, Mark N Melkonyan, Ann H Partridge, Dejan Juric, Jeffrey M Peppercorn, Heather A Parsons, Seth A Wander, Victoria Attaya, Brenda Lormil, Maria Shellock, Aiko Nagayama, Veerle Bossuyt, Steven Jay Isakoff, Sara M Tolaney, Leif W Ellisen
Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Yumin Wang, Boya Gao, Luyuan Zhang, Xudong Wang, Xiaolan Zhu, Haibo Yang, Fengqi Zhang, Xueping Zhu, Badi Zhou, Sean Yao, Aiko Nagayama, Sanghoon Lee, Jian Ouyang, Siang-Boon Koh, Eric L Eisenhauer, Dominique Zarrella, Kate Lu, Bo R Rueda, Lee Zou, Xiaofeng A Su, Oladapo O Yeku, Leif W Ellisen, Xiao-Song Wang, Li Lan
Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair. Nature communications 15 (1) (2024)
Arielle J Medford, Leif W Ellisen
Optimizing Access to Liquid Biopsy in the Present and Future Cancer Landscape. JCO precision oncology 8 (2024)
Yumin Wang, Boya Gao, Luyuan Zhang, Xudong Wang, Xiaolan Zhu, Haibo Yang, Fengqi Zhang, Xueping Zhu, Badi Zhou, Sean Yao, Aiko Nagayama, Sanghoon Lee, Jian Ouyang, Siang-Boon Koh, Eric L Eisenhauer, Dominique Zarrella, Kate Lu, Bo R Rueda, Lee Zou, Xiaofeng A Su, Oladapo O Yeku, Leif W Ellisen, Xiao-Song Wang, Li Lan
Author Correction: Meiotic protein SYCP2 confers resistance to DNA-damaging agents through R-loop-mediated DNA repair. Nature communications 15 (1) (2024)
Arielle J Medford, Leif W Ellisen
Optimizing Access to Liquid Biopsy in the Present and Future Cancer Landscape. JCO precision oncology 8 (2024)
Aditya Bardia, Sheng Sun, Nayana Thimmiah, James T T Coates, Bogang Wu, Rachel Occhiogrosso Abelman, Laura M Spring, Beverly Moy, Phoebe Ryan, Mark N Melkonyan, Ann H Partridge, Dejan Juric, Jeffrey M Peppercorn, Heather A Parsons, Seth A Wander, Victoria Attaya, Brenda Lormil, Maria Shellock, Aiko Nagayama, Veerle Bossuyt, Steven Jay Isakoff, Sara M Tolaney, Leif W Ellisen
Antibody-Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Jamie O Brett, Taronish D Dubash, Gabriela N Johnson, Andrzej Niemierko, Veronica Mariotti, Leslie S L Kim, Jing Xi, Apurva Pandey, Siobhan Dunne, Azadeh Nasrazadani, Maxwell R Lloyd, Avinash Kambadakone, Laura M Spring, Douglas S Micalizzi, Maristela L Onozato, Dante Che, Utthara Nayar, Adam M Brufsky, Kevin M Kalinsky, Cynthia X Ma, Joyce O'Shaughnessy, Hyo S Han, Anthony J Iafrate, Lianne Y Ryan, Dejan Juric, Beverly Moy, Leif W Ellisen, Shyamala Maheswaran, Nikhil Wagle, Daniel A Haber, Aditya Bardia, Seth A Wander
A Gene Panel Associated With Abemaciclib Utility in ESR1 -Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression. JCO precision oncology 7 (2023)
Rachel Occhiogrosso Abelman, Bogang Wu, Laura M Spring, Leif W Ellisen, Aditya Bardia
Mechanisms of Resistance to Antibody-Drug Conjugates. Cancers 15 (4) (2023)
Neelima Vidula, Andrzej Niemierko, Katherine Hesler, Lianne Ryan, Beverly Moy, Steven Jay Isakoff, Leif W Ellisen, Dejan Juric, Aditya Bardia
Utilizing cell-free DNA to predict risk of developing brain metastases in patients with metastatic breast cancer. NPJ breast cancer 9 (1) (2023)
Jamie O Brett, Taronish D Dubash, Gabriela N Johnson, Andrzej Niemierko, Veronica Mariotti, Leslie S L Kim, Jing Xi, Apurva Pandey, Siobhan Dunne, Azadeh Nasrazadani, Maxwell R Lloyd, Avinash Kambadakone, Laura M Spring, Douglas S Micalizzi, Maristela L Onozato, Dante Che, Utthara Nayar, Adam M Brufsky, Kevin M Kalinsky, Cynthia X Ma, Joyce O'Shaughnessy, Hyo S Han, Anthony J Iafrate, Lianne Y Ryan, Dejan Juric, Beverly Moy, Leif W Ellisen, Shyamala Maheswaran, Nikhil Wagle, Daniel A Haber, Aditya Bardia, Seth A Wander
A Gene Panel Associated With Abemaciclib Utility in ESR1 -Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression. JCO precision oncology 7 (2023)
Rachel Occhiogrosso Abelman, Bogang Wu, Laura M Spring, Leif W Ellisen, Aditya Bardia
Mechanisms of Resistance to Antibody-Drug Conjugates. Cancers 15 (4) (2023)
Rachel Occhiogrosso Abelman, Bogang Wu, Laura M Spring, Leif W Ellisen, Aditya Bardia
Mechanisms of Resistance to Antibody-Drug Conjugates. Cancers 15 (4) (2023)
Laura M Spring, Lindsey Mortensen, Elizabeth Abraham, Jennifer Keenan, Arielle J Medford, Annie Ma, Sarah Padden, Elyssa N Denault, Lianne Ryan, A John Iafrate, Jochen K Lennerz, Ephraim P Hochberg, Seth A Wander, Beverly Moy, Steven Jay Isakoff, Dejan Juric, Kimberly A Brennan, Deborah E Smith, Barbara Civiello, Therese Marie Mulvey, Amy H Comander, Leif W Ellisen, Joel H Schwartz, Aditya Bardia
Virtual Molecular and Precision Medicine Clinic to Improve Access to Clinical Trials for Patients With Metastatic Breast Cancer: An Academic/Community Collaboration. JCO oncology practice (2023)
Syed Ia Bukhari, Samuel S Truesdell, Chandreyee Datta, Pritha Choudhury, Keith Q Wu, Jitendra Shrestha, Ruby Maharjan, Ethan Plotsker, Ramzi Elased, Sadia Laisa, Vijeta Bhambhani, Yue Lin, Johannes Kreuzer, Robert Morris, Siang-Boon Koh, Leif W Ellisen, Wilhelm Haas, Amy Ly, Shobha Vasudevan
Regulation of RNA methylation by therapy treatment, promotes tumor survival. bioRxiv : the preprint server for biology (2023)
Laura M Spring, Hyo Han, Minetta C Liu, Erika Paige Hamilton, Hanna Irie, Cesar A Santa-Maria, James Reeves, Peng Pan, Ming Shan, Yongqiang Tang, Julie R Graham, Sebastien Hazard, Leif W Ellisen, Steven Jay Isakoff
Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer. Nature cancer 3 (8) (2022)
Siang-Boon Koh, Brian N Dontchos, Veerle Bossuyt, Christine Edmonds, Simona Cristea, Nsan Melkonjan, Lindsey Mortensen, Annie Ma, Kassidy Beyerlin, Elyssa Denault, Elizabeth Niehoff, Taghreed Hirz, David B Sykes, Franziska Michor, Michelle Specht, Constance Lehman, Leif W Ellisen, Laura M Spring
Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analyses. NPJ precision oncology 5 (1) (2021)
Jee-Eun Choi, Carlos Sebastian, Christina M Ferrer, Caroline A Lewis, Moshe Sade-Feldman, Thomas J LaSalle, Anna L K Gonye, Begona G C Lopez, Walid M Abdelmoula, Michael S Regan, Murat Cetinbas, Gloria Pascual, Gregory R Wojtkiewicz, Giorgia G Silveira, Ruben Boon, Kenneth N Ross, Michael Mints, Srinivas V Saladi, Leif W Ellisen, Ruslan I Sadreyev, Salvador Aznar Benitah, Nathalie Y R Agar, Nir Hacohen, Raul Mostoslavsky
A unique subset of glycolytic tumour-propagating cells drives squamous cell carcinoma. Nature metabolism 3 (2) (2021)
James T Coates, Sheng Sun, Ignaty Leshchiner, Nayana Thimmiah, Elizabeth E Martin, Daniel E McLoughlin, Brian P Danysh, Kara Slowik, Raquel A Jacobs, Kahn Rhrissorrakrai, Filippo Utro, Chaya Levovitz, Elyssa Denault, Charlotte S Walmsley, Avinash Kambadakone, James R Stone, Steven Jay Isakoff, Laxmi Parida, Dejan Juric, Gad A Getz, Aditya Bardia, Leif W Ellisen
Parallel Genomic Alterations of Antigen and Payload Targets Mediate Polyclonal Acquired Clinical Resistance to Sacituzumab Govitecan in Triple-Negative Breast Cancer. Cancer discovery 11 (10) (2021)
Neelima Vidula, Andrzej Niemierko, Giuliana Malvarosa, Megan Yuen, Jochen K Lennerz, A John Iafrate, Seth A Wander, Laura Spring, Dejan Juric, Steven Jay Isakoff, Jerry Younger, Beverly Moy, Leif W Ellisen, Aditya Bardia
Tumor Tissue- versus Plasma-based Genotyping for Selection of Matched Therapy and Impact on Clinical Outcomes in Patients with Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (12) (2021)
Siang-Boon Koh, Kenneth Ross, Steven Jay Isakoff, Nsan Melkonjan, Lei He, Karina J Matissek, Andrew Schultz, Erica L Mayer, Tiffany A Traina, Lisa Anne Carey, Hope S Rugo, Minetta C Liu, Vered Stearns, Adam Langenbucher, Srinivas Vinod Saladi, Sridhar Ramaswamy, Michael S Lawrence, Leif W Ellisen
RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (17) (2021)
Mihriban Karaayvaz-Yildirim, Rebecca E Silberman, Adam Langenbucher, Srinivas Vinod Saladi, Kenneth N Ross, Elena Zarcaro, Andrea Desmond, Murat Yildirim, Varunika Vivekanandan, Hiranmayi Ravichandran, Ravindra Mylvaganam, Michelle C Specht, Sridhar Ramaswamy, Michael S Lawrence, Angelika Amon, Leif W Ellisen
Aneuploidy and a deregulated DNA damage response suggest haploinsufficiency in breast tissues of BRCA2 mutation carriers. Science advances 6 (5) (2020)
Neelima Vidula, Taronish Dubash, Michael S Lawrence, Antoine Simoneau, Andrzej Niemierko, Erica Blouch, Becky Nagy, Whijae Roh, Brian Chirn, Brittany A Reeves, Giuliana Malvarosa, Jochen K Lennerz, Steven J Isakoff, Dejan Juric, Douglas S Micalizzi, Seth Wander, Laura Spring, Beverly Moy, Kristen Shannon, Jerry Younger, Richard B Lanman, Mehmet Toner, A John Iafrate, Gad A Getz, Lee Zou, Leif W Ellisen, Shyamala Maheswaran, Daniel A Haber, Aditya Bardia
Identification of Somatically Acquired BRCA1/2 Mutations by cfDNA Analysis in Patients with Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (18) (2020)
Shuxi Qiao, Siang-Boon Koh, Varunika Vivekanandan, Devika Salunke, Krushna Chandra Patra, Elma Zaganjor, Kenneth Ross, Yusuke Mizukami, Sarah Jeanfavre, Athena Chen, Mari Mino-Kenudson, Sridhar Ramaswamy, Clary Clish, Marcia Haigis, Nabeel Bardeesy, Leif W Ellisen
REDD1 loss reprograms lipid metabolism to drive progression of RAS mutant tumors. Genes & development 34 (11-12) (2020)

Leif W Ellisen.css-eqlu8i{font-size:small;padding-left:4px;} (Leif Ellisen)

Publication Activity (10 Years)

Top Topics

Top Venues

Leif W Ellisen (Leif Ellisen)